|
|
Article: Charles River Releases 3Q 2009 Results.
- Article from:
- Health & Beauty Close-Up
- Article date:
- November 6, 2009
CopyrightCOPYRIGHT 2009 Close-Up Media, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Charles River Laboratories International, Inc. has reported its results for the third quarter of 2009.
In a release on November 3, the Company noted that for the quarter, net sales were $297.5 million, a decline of 13.1 percent from $342.2 million in the third quarter of 2008, primarily driven by lower sales in the Preclinical Services (PCS) segment. Foreign currency translation reduced net sales by 1.8 percent.
On a GAAP basis, net income for the third quarter of 2009 was $37.3 million, or $0.57 per diluted share, compared to net income of $45.5 million, or $0.64 per diluted share, for the third quarter of 2008.
On a non-GAAP basis, net income ...